Inventor · disambiguated record
Kristin Patterson
Also filed as: PATTERSON KRISTIN
28 granted patents·9 pending applications·142 citations·filing 2021–2025
96Inventor score
Files withSPRINGWORKS THERAPEUTICS INC37
Top patents by PatentIndex Score
37 records- 0197US11571402B2Dispersible formulations of N-((R)-2,3-dihydroxypropoly)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereofSPRINGWORKS THERAPEUTICS INC·Filed 2021·Granted Feb 7, 2023·7 cites·11 claims
- 0296US11957662B2Treatments with nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2023·Granted Apr 16, 2024·8 cites·17 claims
- 0396US11951096B2Treatments with nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2023·Granted Apr 9, 2024·8 cites·25 claims
- 0496US11938116B2Treatments with nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2023·Granted Mar 26, 2024·8 cites·17 claims
- 0596US11925620B1Treatments with nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2023·Granted Mar 12, 2024·8 cites·19 claims
- 0696US11925619B2Treatments with nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2023·Granted Mar 12, 2024·8 cites·16 claims
- 0796US11872211B2Treatments with nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2023·Granted Jan 16, 2024·12 cites·22 claims
- 0895US12090128B2Dispersible formulations of n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benazmide and uses thereofSPRINGWORKS THERAPEUTICS INC·Filed 2024·Granted Sep 17, 2024·2 cites·23 claims
- 0995US12029711B1Dosage forms of mirdametinibSPRINGWORKS THERAPEUTICS INC·Filed 2024·Granted Jul 9, 2024·6 cites·30 claims
- 1095US11427534B1Solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide and uses thereofSPRINGWORKS THERAPEUTICS INC·Filed 2021·Granted Aug 30, 2022·19 cites·6 claims
- 1195US11084780B1Crystalline solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereofSPRINGWORKS THERAPEUTICS INC·Filed 2021·Granted Aug 10, 2021·24 cites·15 claims
- 1294US12138246B2Treatments with nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2024·Granted Nov 12, 2024·2 cites·28 claims
- 1394US12036207B2Treatments with nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2023·Granted Jul 16, 2024·2 cites·18 claims
- 1494US12011435B2Treatments with nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2024·Granted Jun 18, 2024·2 cites·30 claims
- 1594US12011434B2Treatments with nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2023·Granted Jun 18, 2024·2 cites·17 claims
- 1694US11884610B2Crystalline solids of mek inhibitor n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereofSPRINGWORKS THERAPEUTICS INC·Filed 2022·Granted Jan 30, 2024·2 cites·6 claims
- 1794US11807611B2Chlorinated tetralin compounds and pharmaceutical compositionsSPRINGWORKS THERAPEUTICS INC·Filed 2023·Granted Nov 7, 2023·3 cites·19 claims
- 1894US11612588B1Chlorinated tetralin compounds and pharmaceutical compositionsSPRINGWORKS THERAPEUTICS INC·Filed 2022·Granted Mar 28, 2023·5 cites·14 claims
- 1994US11504354B1Chlorinated tetralin compounds and pharmaceutical compositionsSPRINGWORKS THERAPEUTICS INC·Filed 2022·Granted Nov 22, 2022·8 cites·12 claims
- 2093US11844780B2Chlorinated tetralin compounds and pharmaceutical compositionsSPRINGWORKS THERAPEUTICS INC·Filed 2023·Granted Dec 19, 2023·2 cites·17 claims
- 2192US12234210B2Synthesis of nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2023·Granted Feb 25, 2025·2 cites·4 claims
- 2292US12110277B2Synthesis of nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2022·Granted Oct 8, 2024·2 cites·13 claims
- 2388US12383517B2Dosage forms of mirdametinibSPRINGWORKS THERAPEUTICS INC·Filed 2024·Granted Aug 12, 2025·0 cites·22 claims
- 2485US12275688B2Crystalline solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereofSPRINGWORKS THERAPEUTICS INC·Filed 2024·Granted Apr 15, 2025·0 cites·20 claims
- 2584US12357597B2Dispersible formulations of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benazmide and uses thereofSPRINGWORKS THERAPEUTICS INC·Filed 2023·Granted Jul 15, 2025·0 cites·28 claims
- 2680US12186305B2Treatments with nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2024·Granted Jan 7, 2025·0 cites·16 claims
- 2780US2023091097A1Chlorinated tetralin compounds and pharmaceutical compositionsSPRINGWORKS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2878US2024217937A1Chlorinated tetralin compounds and pharmaceutical compositionsSPRINGWORKS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2977US12247012B2Synthesis of nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2022·Granted Mar 11, 2025·0 cites·15 claims
- 3076US2025025446A1Treatments with nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3173US2025361212A1Synthesis of nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3272US2025270166A1Crystalline solids of mek inhibitor n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo--phenylamino)-benzamide and uses thereofSPRINGWORKS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3369US11780800B1Fluorinated phenylamino compounds and pharmaceutical compositionsSPRINGWORKS THERAPEUTICS INC·Filed 2023·Granted Oct 10, 2023·0 cites·18 claims
- 3469US2023087828A1Solid state forms of (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-n-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1h-imidazol-4-yl)pentanamide and uses thereofSPRINGWORKS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3567US2023049311A1Methods of treating desmoid tumors with (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-n-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1h-imidazol-4-yl)pentanamideSPRINGWORKS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3666US2024180874A1Improved treatment of ovarian cancer with nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3765US2024316007A1Compositions and treatments with nirogacestatSPRINGWORKS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kristin Patterson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →